Microbot Medical Inc

Microbot Medical Inc

MBOT · NASDAQ · Healthcare / Medical Devices

0.9787USD-0.05 (-4.98%)

Price History

Full chart

Market Stats

Previous Close1.03
Open1.04
Day Range0.9503 – 1.05
52-Week Range1.24 – 3.46
Volume1.16M
Market Cap85.64M
P/E (TTM)0.00
Forward P/E31.75
EPS-0.25
Dividend Yield0.00%
Beta1.03
50-Day Avg1.59
200-Day Avg1.99

About

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Harel Gadot
  • Employees43
  • Headquarters175 Derby Street, Hingham, MA, United States, 02043, USA
  • Websitehttps://microbotmedical.com

Leadership

  • Mr. Harel GadotCo-Founder, President, CEO & Chairman · b. 1973
  • Ms. Rachel VakninChief Financial Officer · b. 1979
  • Dr. Simon Sharon MBA, MScCTO & GM of Microbot Israel · b. 1960
  • Dr. Juan Diaz-CartelleChief Medical Officer · b. 1976
  • Ms. Christina BaileyVice President of Sales
  • Ms. Allison RosefortVice President of Marketing
  • Naama MoavVice President of Human Resources
  • Mr. Michael LytleHead of Sales Operations & Analytics

Financials

Income Statement

Currency: USD1991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue500.00K1.40M3.00M1.30M11.80M7.10M10.60M8.80M5.02M74.30K805.23K415.38K273.43K141.03K205.91K92.85K56.72K231.73K992.87K1.43M1.22M1.37M1.20M1.01M117.00K0000000000
Growth (%)-+180.00%+114.29%-56.67%+807.69%-39.83%+49.30%-16.95%-42.95%-98.52%+983.76%-48.42%-34.17%-48.42%+46.00%-54.91%-38.91%+308.54%+328.46%+43.72%-14.44%+12.04%-12.06%-15.88%-88.44%-100.00%---------
Cost of Revenue4.70M7.40M10.30M-1.80M-1.50M-1.80M-2.10M-2.80M-2.05M-2.78M---1.04M1.08M1.04M1.18M1.19M261.44K168.42K214.81K263.19K316.63K-39117.00K10.00K21.00K54.00K84.00K68.00K76.00K102.00K106.00K91.00K47.00K
Gross Profit-4.20M-6.00M-7.30M3.10M13.30M8.90M12.70M11.60M7.07M2.86M805.23K415.38K273.43K-897.00K-877.00K-952.00K-1.12M-955.00K-963.00K-262.00K1.01M1.10M1.20M1.01M117.00K-10.00K-21.00K-54.00K-84.00K-68.00K-76.00K-102.00K-106.00K-91.00K-47.00K
Gross Margin-840.00%-428.57%-243.33%238.46%112.71%125.35%119.81%131.81%140.74%3846.57%100.00%100.00%100.00%-636.02%-425.91%-1025.31%-1971.02%-412.12%-96.99%-18.36%82.39%80.77%100.00%100.00%100.00%----------
Operating Expense-10.60M-15.70M-19.50M-13.80M5.80M-6.80M26.90M-1.90M16.96M-6.41M-10.78M-9.79M-11.87M11.68M12.68M-22.32M-29.71M-27.69M-30.34M28.88M28.14M23.29M1.20M31.92M36.84M9.63M5.25M7.19M7.16M9.02M11.28M13.18M9.75M11.53M14.70M
Operating Income6.40M9.70M12.20M16.90M7.50M15.70M-14.20M13.50M-9.89M9.27M11.59M10.21M12.15M-12.57M-13.56M21.37M28.59M26.74M29.38M-29.14M-27.13M-22.19M-805.29-30.91M-36.72M-9.63M-5.27M-7.24M-7.24M-9.09M-11.36M-13.28M-9.86M-11.63M-14.74M
Operating Margin1280.00%692.86%406.67%1300.00%63.56%221.13%-133.96%153.36%-196.93%12471.06%1438.84%2458.01%4442.09%-8914.87%-6585.76%23016.69%50405.49%11538.43%2958.90%-2041.91%-2222.28%-1622.00%-0.07%-3054.35%-31384.62%----------
EBITDA-6.00M-8.90M-10.70M-15.10M-6.00M-13.90M-12.10M-10.70M-7.84M-6.48M-9.70M-9.81M-11.13M-13.53M-14.95M-17.76M-23.73M-25.55M-27.03M-23.63M-20.05M-26.93M-23.76M-29.66M-36.61M-9.63M-5.25M-7.17M-7.06M-9.02M-11.24M-13.34M-10.63M-11.35M-13.10M
EBITDA Margin-1200.00%-635.71%-356.67%-1161.54%-50.85%-195.77%-114.15%-121.52%-156.17%-8725.44%-1204.00%-2361.23%-4071.61%-9595.56%-7260.80%-19128.70%-41826.80%-11026.63%-2722.81%-1655.85%-1642.01%-1968.49%-1975.16%-2930.63%-31291.45%----------
Net Income-6.40M-10.00M-12.50M-16.50M-8.90M-13.80M-18.10M-12.60M-15.71M-11.34M-3.45M-10.37M-12.29M-15.33M-11.74M-18.95M-25.02M-29.09M-27.03M-25.24M-21.33M-28.49M-26.44M-32.74M-36.41M-9.66M-7.59M-7.26M-7.25M-9.17M-11.31M-13.17M-10.74M-11.44M-13.14M
Net Income Margin-1280.00%-714.29%-416.67%-1269.23%-75.42%-194.37%-170.75%-143.13%-312.80%-15263.80%-427.95%-2495.32%-4495.12%-10869.72%-5700.44%-20407.11%-44115.16%-12552.11%-2722.01%-1769.03%-1746.85%-2082.68%-2197.77%-3235.28%-31123.93%----------
R&D---13.50M14.70M17.10M18.60M17.70M9.98M5.98M8.60M6.40M6.14M8.76M8.93M13.60M19.94M17.81M19.93M21.02M19.94M15.85M19.37M21.50M823.00K1.11M1.28M2.86M2.97M3.40M6.15M7.74M5.72M6.63M6.28M
R&D as % of Total Revenue---1038.46%124.58%240.85%175.47%201.07%198.81%8047.11%1068.39%1540.77%2247.01%6211.27%4336.28%14647.28%35148.62%7684.81%2007.31%1472.95%1632.92%1158.41%1610.05%2124.80%703.42%----------
Interest Expense100.00K200.00K400.00K400.00K700.00K600.00K600.00K500.00K0272.51K0226.72K207.11K191.01K171.91K143.00K123.61K109.76K110.81K93.38K71.36K50.19K1.17M1.29M506.32K334.00K238.00K0103.00K80.00K44.00K131.28M---
Interest Expense % of Total Revenue20.00%14.29%13.33%30.77%5.93%8.45%5.66%5.68%0.00%366.77%0.00%54.58%75.75%135.43%83.49%154.01%217.92%47.37%11.16%6.54%5.84%3.67%96.99%127.96%432.75%----------

Balance Sheet

Currency: USD1991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets17.30M35.20M41.00M32.20M56.80M58.40M44.30M32.90M15.78M29.79M20.80M11.33M19.79M47.63M44.84M66.86M48.28M41.23M51.19M30.60M25.21M30.17M41.56M32.43M21.22M3.37M11.02M6.09M37.13M26.28M16.77M9.54M8.33M6.03M81.54M
Total Liabilities2.40M6.00M6.50M9.60M11.40M23.70M15.40M15.00M12.27M6.81M7.60M7.54M8.82M10.68M12.46M12.48M13.07M19.42M20.70M15.12M14.48M16.19M26.60M26.56M21.55M1.67M1.06M4.76M5.59M1.97M2.39M2.25M3.83M2.50M3.99M
Total Equity14.90M29.20M34.50M22.60M45.40M34.70M35.00M17.90M3.51M22.98M13.21M3.79M10.96M36.95M32.38M54.38M35.21M21.81M30.50M15.48M10.73M13.98M14.95M5.87M-334.00K1.70M9.96M1.33M31.54M24.31M14.38M7.29M4.50M3.53M77.55M
Cash14.70M6.80M8.40M8.70M9.50M19.90M15.90M7.90M4.76M6.07M13.70M4.24M13.08M41.06M34.54M51.80M9.76M30.04M38.62M19.71M13.31M8.47M30.59M24.99M12.11M2.71M10.79M5.24M28.77M19.65M13.49M2.52M2.47M3.11M3.91M
Total Debt1.10M4.50M4.10M6.60M6.50M9.40M5.20M5.10M3.26M2.94M2.60M2.32M2.09M1.94M1.66M1.35M1.19M1.03M1.01M784.58K540.48K350.78K12.94M15.03M10.35M76.00K--903.00K813.00K680.00K462.00K231.00K111.00K865.00K
Net Debt-13.60M-2.30M-4.30M-2.10M-3.00M-10.50M-10.70M-2.80M-1.50M-3.13M-11.09M-1.92M-11.00M-39.12M-34.23M-50.44M-8.57M-29.01M-37.60M-18.92M-12.77M-8.12M-17.68M-9.97M-1.78M-2.63M-10.79M-5.24M-27.87M-18.84M-12.81M-2.06M-2.24M-3.00M-3.05M

Cash Flow

Currency: USD1991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-5.10M-8.90M-11.90M-13.40M-4.00M-10.00M-13.80M-9.20M-12.49M-6.32M-10.52M-10.09M-8.54M-11.27M-11.87M-16.10M-20.86M-22.74M-24.68M-24.52M-22.06M-19.87M-23.32M-27.35M-765.00K-786.00K-4.86M-5.31M-6.45M-7.25M-9.35M-11.55M-8.53M-8.83M-13.05M
Investing Cash Flow2.60M-26.20M-3.80M7.20M-26.40M-10.30M1.00M9.97M389.72K7.74M-222.34K-189.73K-748.30K-847.50K-1.30M-27.16M24.22M3.73M-923.96K-3.42M-10.69M9.04M-425.62K-2.00K-25.00K-58.00K-223.00K-2.45M-2.77M3.20M-3.84M1.97M1.54M-72.38M
Financing Cash Flow15.30M27.10M17.20M6.70M31.20M13.80M-300.00K100.00K-1.15M7.24M10.41M848.81K17.58M40.00M6.20M34.66M5.98M18.80M29.79M6.59M19.13M25.74M36.40M22.20M413.00K3.08M13.02M-18.00K36.77M-3.38M4.32M4.32M6.56M7.94M86.24M
Capital Expenditure700.00K5.00M1.00M3.70M1.40M4.40M10.20M2.60M192.75K151.21K334.32K222.34K189.73K676.14K847.50K1.26M1.32M337.36K716.24K923.96K296.93K73.08K4.68M903.94K2.00K25.00K58.00K223.00K216.00K91.00K69.00K84.00K33.00K25.00K60.00K
Free Cash Flow-5.80M-13.90M-12.90M-17.10M-5.40M-14.40M-24.00M-11.80M-12.68M-6.47M-10.85M-10.31M-8.73M-11.95M-12.72M-17.36M-22.18M-23.08M-25.40M-25.44M-22.36M-19.94M-28.00M-28.26M-767.00K-811.00K-4.91M-5.53M-6.67M-7.34M-9.42M-11.63M-8.57M-8.85M-13.11M
Dividends Paid-----------10.37B12.29B15.33B11.74B-----0014.43M8.25M000--------
FCF to OCF113.73%156.18%108.40%127.61%135.00%144.00%173.91%128.26%101.54%102.39%103.18%102.20%102.22%106.00%107.14%107.82%106.33%101.48%102.90%103.77%101.35%100.37%120.07%103.30%100.26%103.18%101.19%104.20%103.35%101.25%100.74%100.73%100.39%100.28%100.46%
Dividend Paid to FCF------------100537.49%-140740.32%-128286.53%-92296.61%-----0.00%0.00%-51.55%-29.20%0.00%0.00%0.00%--------

Earnings

Report DateJan 22, 1996Feb 6, 1997May 6, 1997Jul 28, 1997Nov 19, 1997Feb 10, 1998Mar 31, 1998Jun 30, 1998Sep 30, 1998Mar 31, 1999Jun 30, 1999Sep 30, 1999Mar 31, 2000Jun 30, 2000Sep 30, 2000Dec 31, 2000Mar 31, 2001Jun 30, 2001Sep 30, 2001Dec 31, 2001Mar 31, 2002Jun 30, 2002Sep 30, 2002Dec 31, 2002Mar 31, 2003Aug 5, 2003Oct 23, 2003May 3, 2004Jul 30, 2004Oct 25, 2004Mar 4, 2005May 2, 2005Jul 29, 2005Oct 28, 2005Mar 16, 2006Apr 28, 2006Aug 1, 2006Nov 1, 2006Feb 28, 2007May 7, 2007Jul 31, 2007Nov 5, 2007Mar 14, 2008May 6, 2008Aug 5, 2008Nov 4, 2008Mar 16, 2009May 8, 2009Aug 10, 2009Nov 5, 2009Mar 11, 2010May 4, 2010Aug 10, 2010Nov 3, 2010Mar 11, 2011May 4, 2011Jul 28, 2011Nov 1, 2011Mar 13, 2012May 10, 2012Aug 2, 2012Nov 8, 2012Mar 19, 2013May 10, 2013Aug 7, 2013Nov 5, 2013Mar 12, 2014May 14, 2014Aug 12, 2014Nov 5, 2014Mar 13, 2015May 5, 2015Aug 6, 2015Nov 2, 2015Mar 15, 2016May 10, 2016Aug 15, 2016Nov 3, 2016May 15, 2017Aug 14, 2017Nov 14, 2017Mar 22, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Mar 31, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Mar 26, 2020May 15, 2020Aug 14, 2020Nov 16, 2020Mar 31, 2021May 17, 2021Aug 16, 2021Nov 15, 2021Mar 31, 2022May 16, 2022Aug 15, 2022Nov 14, 2022Mar 31, 2023May 17, 2023Aug 14, 2023Nov 14, 2023Mar 27, 2024May 15, 2024Aug 14, 2024Nov 13, 2024Mar 25, 2025May 14, 2025Aug 12, 2025Nov 12, 2025Mar 26, 2026May 12, 2026Aug 11, 2026Nov 11, 2026
EPS Estimate-3645.00-3726.0081.00-4050.00-3564.00-4050.00----------------------1620.00-------1782.00------------1134.00-1109.70-1036.80-1093.50-907.20-1134.00-1198.80-1020.60--891.00-688.50-729.00-588.60-421.20-405.00-230.04-221.40-216.00-263.25-218.70-210.60-194.40-230.04-262.44-189.00-226.80-139.32-142.56-142.56-101.25-90.45-85.05----0.04-0.60-0.60-0.60-0.59-0.42-0.45-0.44-0.33-0.28-0.27-0.28-0.34-0.33-0.35-0.36-0.37-0.42-0.45-0.51-0.47-0.45-0.31-0.25-0.25-0.17-0.17-0.17-0.18-0.13-0.08-0.06-0.06-0.08-0.08-0.08
EPS Actual-3240.00-4536.00-4212.00-648.00-3240.00-4212.00-3134.48-3603.43-2541.90-1696.75-1609.98-5809.77-1503.72-444.98-2036.00-5053.35194.491110.63-1258.81-2566.70-2093.51-2356.47-1963.90-1243.87-1641.12-2042.13-1244.87-1134.00-1242.29-1295.67-1295.97-895.25-993.53-23.65-1134.00-1037.95-838.15-1012.89-1226.84-952.55-1101.26-1447.36-1457.96-1313.77-1346.14-1149.31-1782.00-1620.00-1134.00-810.00-810.00-810.00-648.00-648.00-1176.76-680.40-469.80-502.20-696.60-729.00-356.40-874.80-113.40-275.40-243.00-275.40-210.60-226.80-356.40-64.80-178.20-226.80-145.80-145.80-129.60-132.308.10-59.40-0.60-0.09-0.45-0.03-0.45-0.60-0.58-0.72-0.48-0.36-0.44-0.33-0.31-0.26-0.35-0.37-0.34-0.35-0.36-0.54-0.45-0.49-0.49-0.38-0.36-0.25-0.21-0.26-0.17-0.17-0.20-0.20-0.08-0.10-0.07-0.04-0.05-0.08-
Surprise11.11%-21.74%-5300.00%84.00%9.09%-4.00%---------------------30.00%------36.36%------------57.14%-45.99%-9.38%25.93%10.71%28.57%45.95%36.51%-23.64%31.76%31.11%-18.35%-73.08%12.00%-280.28%48.78%-27.50%7.69%-25.93%0.00%-16.67%-54.93%75.31%5.71%0.00%-4.65%-2.27%9.09%-30.67%108.96%30.16%---25.00%25.00%0.00%3.33%-22.03%-14.29%20.00%0.00%0.00%-10.71%3.70%-25.00%-8.82%-3.03%0.00%0.00%-45.95%-7.14%-8.89%3.92%19.15%20.00%19.35%16.00%-4.00%0.00%0.00%-17.65%-11.11%38.46%-25.00%-16.67%33.33%37.50%0.00%-
Timing--------------------------------------------------------------------After-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-Pre-market-

Key Statistics & Ratios

Market Cap85.64M
Enterprise Value26.20M
Trailing P/E0.00
Forward P/E31.75
PEG Ratio0.70
Price / Sales247.50
Price / Book1.35
EPS-0.25
Book Value1.03
Revenue (TTM)346.00K
Gross Profit (TTM)-641.00K
EBITDA-18.46M
Profit Margin0.00%
Operating Margin-2567.64%
Return on Equity-32.91%
Return on Assets-21.72%
Shares Outstanding67.16M
Shares Float67.16M
Beta1.03
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 1 analystsTarget 6.33
  • Buy
    1

Ownership Breakdown

Institutions
17.49%
Insiders
0.00%
Retail / Other
82.51%

Top Institutional Holders

  • Vanguard Capital Management, LLC
    2.91M4.33%
  • CIBC Bancorp USA Inc.
    1.87M2.78%
  • Susquehanna International Group, LLP
    924.31K1.38%
  • BlackRock Inc
    857.40K1.28%
  • UBS Group AG
    816.95K1.22%
  • Geode Capital Management, LLC
    760.83K1.13%
  • DnB NOR Asset Management (Asia)
    677.50K1.01%
  • Stifel Financial Corp
    573.08K0.85%
  • Marshall Wace Asset Management Ltd
    481.05K0.72%
  • Ancora Advisors LLC
    477.08K0.71%
  • Vanguard Fiduciary Trust Co
    400.23K0.60%
  • The Goldman Sachs Group Inc
    309.10K0.46%
  • State Street Corp
    303.57K0.45%
  • AlphaCentric Advisors, LLC
    250.00K0.37%
  • 683 Capital Management LLC
    170.00K0.25%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    2.11M3.14%
  • DNB Fund Disrpt Opps A EUR Acc
    677.50K1.01%
  • Fidelity Extended Market Index
    349.39K0.52%
  • AlphaCentric Robotics and Automation I
    250.00K0.37%
  • iShares Micro-Cap ETF
    229.41K0.34%

Stock Splits

  • Sep 5, 20181:15
  • Nov 29, 20161:9
  • May 9, 20161:12
  • Jul 6, 20111:10